USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study

[1]  Alireza Heidari,et al.  Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) , 2021, Journal of Chemistry and Applications.

[2]  K. Kovitz,et al.  Addressing Gender Disparities in Lung Cancer Screening Eligibility: USPSTF versus PLCOm2012 Criteria. , 2021, Chest.

[3]  L. Rabeneck,et al.  Selection of individuals for lung cancer screening based on risk prediction model performance and economic factors - The Ontario experience. , 2021, Lung cancer.

[4]  M. Cabana,et al.  Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.

[5]  Summer S. Han,et al.  Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. , 2021, JAMA.

[6]  K. Kovitz,et al.  Brief Report: Risk Prediction Model Versus United States Preventive Services Task Force 2020 Draft Lung Cancer Screening Eligibility Criteria—Reducing Race Disparities , 2020, JTO clinical and research reports.

[7]  R. Booton,et al.  Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk , 2020, BMJ Open.

[8]  K. Kovitz,et al.  Risk Prediction Model versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria - Reducing Race Disparities. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  R. Kaaks,et al.  Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data , 2020, European Journal of Epidemiology.

[10]  S. Lam,et al.  Protocol and Rationale for the International Lung Screening Trial , 2020, Annals of the American Thoracic Society.

[11]  V. Valente,et al.  LDCT lung cancer screening in populations at different risk for lung cancer , 2020, BMJ Open Respiratory Research.

[12]  Harry J de Koning,et al.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.

[13]  C. Berg,et al.  Life-GainedBased Versus Risk-Based Selection of Smokers for Lung Cancer Screening , 2019, Annals of Internal Medicine.

[14]  S. Lam,et al.  Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study. , 2019, Journal of the American College of Radiology : JACR.

[15]  H. Kauczor,et al.  Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial , 2019, International journal of cancer.

[16]  Summer S. Han,et al.  Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results , 2019, JAMA network open.

[17]  Xiaodong Yang,et al.  Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades , 2019, Cancer management and research.

[18]  R. Booton,et al.  Second round results from the Manchester ‘Lung Health Check’ community-based targeted lung cancer screening pilot , 2018, Thorax.

[19]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[20]  A. Jemal,et al.  Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening , 2018, Annals of Internal Medicine.

[21]  S. Lam,et al.  Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. , 2017, The Lancet. Oncology.

[22]  S. Lam,et al.  The Cost‐Effectiveness of High‐Risk Lung Cancer Screening and Drivers of Program Efficiency , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  D. Manners,et al.  Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool , 2017, International journal of cancer.

[24]  Harry J de Koning,et al.  Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study , 2017, PLoS medicine.

[25]  B. Kramer,et al.  Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. , 2016, The Lancet. Oncology.

[26]  J. Wardle,et al.  The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’ patients , 2016, BMC Cancer.

[27]  J. Austin,et al.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[28]  H. Boeing,et al.  Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort , 2015, Cancer Prevention Research.

[29]  Timothy R. Church,et al.  Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts , 2014, PLoS medicine.

[30]  S. Lam,et al.  Probability of cancer in pulmonary nodules detected on first screening CT. , 2013, The New England journal of medicine.

[31]  C. Berg,et al.  Targeting of low-dose CT screening according to the risk of lung-cancer death. , 2013, The New England journal of medicine.

[32]  Timothy R Church,et al.  Selection criteria for lung-cancer screening. , 2013, The New England journal of medicine.

[33]  Charles A Powell,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. , 2011, Proceedings of the American Thoracic Society.

[34]  D B Rubin,et al.  Multiple imputation in health-care databases: an overview and some applications. , 1991, Statistics in medicine.

[35]  Frank C. Detterbeck,et al.  The Eighth Edition Lung Cancer Stage Classification , 2017, Chest.

[36]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .